Researchers curious about hexarelin vs
Free from harsh chemicals & parabens
Among the 47.5 million Medicare Part D enrollees in 2023, 9.7 million enrollees met the clinical criteria for the Medicare GLP-1 Bridge in 2023, but less than half of this group3.8 million (39%)is estimated to be eligible for Bridge (Figure 2, Table 1)
As the market grows, companies will need to find a balance between good nutrition, quality, and price
More extensive, long-term clinical trials are urgently needed to fully elucidate its efficacy, safety profile, and optimal dosing strategies compared to established injectable formulations
Further studies are required to assess the safety of these products